Users' questions

What is Poractant Alfa used for?

What is Poractant Alfa used for?

PORACTANT ALFA is a lung surfactant. Our bodies need lung surfactant to keep the lungs open during breathing. This medicine is used to treat Respiratory Distress Syndrome (RDS) in babies who are born early.

What is CUROSURF made from?

CUROSURF is a natural surfactant, prepared from porcine lungs, containing almost exclusively polar lipids, in particular phosphatidylcholine (about 70% of the total phospholipid content), and about 1% of specific low molecular weight hydrophobic proteins SP-B and SP-C.

How much does CUROSURF cost?

The cost for Curosurf intratracheal suspension (80 mg/mL) is around $525 for a supply of 1.5 milliliters, depending on the pharmacy you visit….Intratracheal Suspension.

Quantity Per unit Price
1.5 milliliters $350.07 $525.11
3 milliliters $342.08 $1,026.23

How many milligrams of poractant alfa are in Curosurf?

1.5 mL [120 mg poractant alfa (surfactant extract)], or 3 mL [240 mg poractant alfa (surfactant extract)]. Curosurf is a white to creamy white suspension. Each mL of suspension contains 80 mg poractant alfa (surfactant extract) that includes 76 mg of phospholipids and 1 mg of protein of which 0.45 mg is SP-B and 0.59 mg is SP-C. None.

What do you need to know about Poractant alfa?

Poractant Alfa (Curosurf) Uses of Poractant Alfa: It is used to treat or prevent lung distress in premature babies. What do I need to tell my doctor BEFORE I take Poractant Alfa? If your child has an allergy to poractant alfa (curosurf) or any part of poractant alfa (curosurf).

Which is porcine lung surfactant does Curosurf contain?

Curosurf is an extract of natural porcine lung surfactant consisting of 99% polar lipids (mainly phospholipids) and 1% hydrophobic low molecular weight proteins (surfactant associated proteins SP-B and SP-C). Curosurf is a white to creamy white suspension of poractant alfa.

How is Curosurf used in the treatment of RDS?

CUROSURF ® (poractant alfa) Intratracheal Suspension is indicated for the rescue treatment of Respiratory Distress Syndrome (RDS) in premature infants.